Volume-selective 1H MR spectroscopy for in vivo detection of valproate in patients with epilepsy

[1]  C Boesch,et al.  Characterization of the macromolecule baseline in localized 1H‐MR spectra of human brain , 2001, Magnetic resonance in medicine.

[2]  C Gössl,et al.  Improved analysis of 1H‐MR spectra in the presence of mobile lipids , 2001, Magnetic resonance in medicine.

[3]  J. Bernarding,et al.  Volume-selective proton MR spectroscopy for in-vitro quantification of anticonvulsants , 2001, Neuroradiology.

[4]  R. Mattson,et al.  Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures , 1999, Seizure.

[5]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[6]  R. Mattson.  Efficacy and Adverse Effects of Established and New Antiepileptic Drugs * , 1995, Epilepsia.

[7]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[8]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[9]  T. May,et al.  Postmortem Concentrations of Phenobarbital, Carbamazepine, and Its Metabolite Carbamazepine‐10,11‐Epoxide in Different Regions of the Brain and in the Serum: Analysis of Autoptic Specimens from 51 Epileptic Patients , 1993, Therapeutic drug monitoring.

[10]  G. Ojemann,et al.  Low and variable presence of valproic acid in human brain , 1992, Neurology.

[11]  T. May,et al.  Postmortem Concentrations of Phenytoin in Different Regions of the Brain and in the Serum: Analysis of Autoptic Specimens from 24 Epileptic Patients , 1992, Therapeutic drug monitoring.

[12]  T. May,et al.  Postmortem Serum Protein Binding and Brain Concentrations of Antiepileptic Drugs in Autoptic Specimens from 45 Epileptic Patients , 1990, Therapeutic drug monitoring.

[13]  J. Hermans,et al.  Distribution of drugs over whole blood: II. The transport function of whole blood for phenytoin. , 1989, Therapeutic drug monitoring.

[14]  O. Driessen,et al.  Distribution of drugs over whole blood: I. The transport function of whole blood for valproate. , 1989, Therapeutic drug monitoring.

[15]  H. Ehmke,et al.  Influence of the renin-angiotensin system on the autoregulation of renal blood flow and glomerular filtration rate in conscious dogs. , 1988, Acta physiologica Scandinavica.

[16]  C. L. Zimmerman,et al.  Protein Binding of Valproic Acid in the Presence of Elevated Free Fatty Acids in Patient and Normal Human Serum , 1981, Epilepsia.

[17]  D. Fellman.  ANTICONVULSANT THERAPY , 1980, Neurology.

[18]  E. Persson.  Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). , 1988, Acta medica Scandinavica. Supplementum.